ADSI

from Wikipedia, the free encyclopedia
ADSI - Austrian Drug Screening Institute GmbH
founding 2011
Sponsorship University of Innsbruck
place Innsbruck , Austria
Scientific Director
Commercial Director 		Günther Bonn
Markus Pasterk
Employee 25th
Website [1]

The Austrian Drug Screening Institute GmbH (ADSI) is a chemical-biological research facility that acts as a link between the university and the company.

It was founded in 2011 with the University of Innsbruck as 100% owner. The founding fathers were the two university professors Günther Bonn from the University of Innsbruck and Lukas Huber from the Medical University of Innsbruck .

The aim of the institute is to develop processes for companies in the phytopharma, phytocosmetics and phyto-nutrition sectors or to offer self-developed test systems as a research service.

The core budget for the ongoing operation of the ADSI is currently made available through funding from the Austrian Federal Government by way of the performance agreement with the Ministry of Science and the government of the state of Tyrol . Substantial further funds are obtained from orders from the economy and project funding. The European Commission with its research framework programs such as H2020 and regional development programs such as B. Interreg . The ADSI takes part in the following EU projects: PreCanMed, Olivnet. There are scientific collaborations with the companies Bionorica SE from Germany, Cura Cosmetics from Austria and Weleda AG.

The ADSI is also the nucleus of the "Phytovalley Tirol", in which all plant science R&D facilities in Tyrol are bundled and given a brand. A separate annual conference was also set up for this purpose: " Austrian Summit on Natural Products ", which was held for the second time in 2019 and drew around 110 scientists from Europe and beyond to Seefeld , Tyrol.

Individual evidence

  1. ^ ADSI GmbH: ADSI. Retrieved February 25, 2019 .
  2. ↑ Commercial Register ABC: ADSI - Austrian Drug Screening Institute GmbH, Innsbruck, Tyrol. Retrieved February 26, 2019 .
  3. ↑ Stefan Stuppner: About us. In: www.adsi.ac.at. Retrieved on February 26, 2019 (German).
  4. ^ University of Innsbruck: Development Plan 2016-2018. University of Innsbruck, May 2015, accessed on February 25, 2019 .
  5. ^ Office of the Tyrolean Provincial Government: Funding of the Austrian Drug Screening Institute until 2021. August 9, 2018, accessed on February 26, 2019 .
  6. ↑ Consortium PreCanMed: PreCanMed - Development of a platform for precision cancer medicine. Retrieved February 26, 2019 .
  7. ↑ CORDIS | European Commission. Retrieved February 26, 2019 .
  8. ^ Christian Flatz, Stefan Hohenwarter: Phytovalley Tirol blooms - University of Innsbruck. Retrieved February 26, 2019 .
  9. ^ Chemical report: The valley of the plants. In: pages 50-51. Josef Brodacz, Rathausplatz 4, 2351 Wiener Neudorf, January 2015, accessed on February 26, 2019 .
  10. ↑ Welcome - PhytoValley. Retrieved on February 26, 2019 (German).
  11. ↑ “Natural pharmacy” in the sights of science. January 13, 2018, accessed February 26, 2019 .
  12. ↑ Scientists discuss quality standards for natural products. Retrieved February 26, 2019 .